Literature DB >> 9115470

Tourette syndrome. Treatment of tics.

R Kurlan1.   

Abstract

There are a number of medications that effectively relieve symptoms in patients with functionally disabling tics. Neuroleptic drugs remain the most predictably effective tic-suppressing agents, but other approaches may be beneficial. This article reviews the spectrum of available therapies to suppress tics and provides practical guidelines for their selection and use.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9115470     DOI: 10.1016/s0733-8619(05)70321-2

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  6 in total

Review 1.  Pharmacological options for the treatment of Tourette's disorder.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Aripiprazole for the treatment of Tourette's disorder.

Authors:  Prasad R Padala; S Faiz Qadri; Vishal Madaan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

Review 3.  Contemporary assessment and pharmacotherapy of Tourette syndrome.

Authors:  Lawrence Scahill; Gerald Erenberg; Cheston M Berlin; Cathy Budman; Barbara J Coffey; Joseph Jankovic; Louise Kiessling; Robert A King; Roger Kurlan; Anthony Lang; Jonathan Mink; Tanya Murphy; Samual Zinner; John Walkup
Journal:  NeuroRx       Date:  2006-04

Review 4.  Tic disorders: from pathophysiology to treatment.

Authors:  Liborio Rampello; Alessandro Alvano; Giuseppe Battaglia; Valeria Bruno; Rocco Raffaele; Francesco Nicoletti
Journal:  J Neurol       Date:  2005-12-05       Impact factor: 6.682

5.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

6.  Neurosurgical strategies for Gilles de la Tourette's syndrome.

Authors:  Karim Mukhida; Matthew Bishop; Murray Hong; Ivar Mendez
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.